Drug firm that hiked prices by 6,000% paid shareholders £400m

Advabz Pharma and its subsidiaries were found to have charged ‘excessive and unfair’ prices between 2009 and 2017. Photograph: Scharvik/Getty Images/iStockphoto

Advabz Pharma and its subsidiaries were found to have charged ‘excessive and unfair’ prices between 2009 and 2017. Photograph: Scharvik/Getty Images/iStockphoto

source https://www.theguardian.com/business/2021/jul/30/drug-firm-that-hiked-prices-by-6000-paid-shareholders-400m